XML 39 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share Capital and Share Premium
12 Months Ended
Dec. 31, 2023
Share Capital and Share Premium [Abstract]  
SHARE CAPITAL AND SHARE PREMIUM

13 SHARE CAPITAL AND SHARE PREMIUM

 

Group

 

On 21 October 2021, the Company acquired the entire shareholding of Tiziana Life Sciences Plc and its subsidiaries through a share for share exchange transaction. On this date Tiziana Life Sciences Ltd became the Group’s parent company. This transaction does not constitute a business combination under IFRS 3 “Business combinations” and has been accounted for as a group reorganization. Merger accounting has been applied to account for the insertion of the new company. Due to a share consolidation, the effect of this was a decrease in share capital of the Company with an offset posted to the merger reserve. As a common control transaction, the Group has elected to present the comparative information as if this transaction had occurred before the start of the comparative period. The share capital arising on the share for share exchange has been presented as share capital in the comparative period.

 

   Nominal
Value
   Share
Capital
   Share
Premium
   Merger
Reserve
 
   £/$   Shares   $000   $000   $000 
At January 1 2021 per 20-F annual report  £0.03    194,612,289    10,794    111,821    
-
 
Group Reorganization                         
Elimination of share capital in Tiziana Life Sciences Plc  £0.03    (194,612,289)   (10,794)   (111,821)   122,615 
Shares issued pursuant to share for share exchange and consolidation  $0.001    97,306,144    97    
-
    (97)
Elimination of other reserves in Tiziana Life Sciences Plc                       (3,821)
Restated at 1 January 2021  $0.001    97,306,144    97    
-
    118,697 
Shares issued in the period:                         
Conversion of warrants  $0.001    136,854    
-
    156    
-
 
Conversion of Loan  $0.001    1,866,907    2    603    
-
 
Issued in lieu of cash bonus  $0.001    2,962,709    3    14,837    
-
 
At 31 December 2021        102,272,614    102    15,596    118,697 
Shares issued in the period:                         
At 31 December 2022        102,272,614    102    15,596    118,697 
Shares issued in lieu of fees  $.0001    450,000    1    300      
Warrants Exercised  $.0001    337,501    
-
    573      
Issuance of Stock - ATM  $.0001    27,629    
-
    23      
At 31 December 2023        103,087,744    103    16,492    118,697 

 

Ordinary Shares

 

Ordinary shares have a par value of $0.001. They entitle the holder to participate in dividends, and to share in the proceeds of winding up the company in proportion to the number of and amounts paid on the shares held. On a show of hands every holder of ordinary shares present at a meeting in person or by proxy is entitled to one vote, and upon a poll each share is entitled to one vote. The Company has 103,087,744 shares in issue and holds 1,573,510 shares in treasury.